Kamada (KMDA) Acquisitions (2021)
Kamada (KMDA) posted quarterly Acquisitions of -$95.0 million for Q4 2021, down 6666.31% on a QoQ basis from -$1.4 million in Q1 2021.
Kamada (KMDA) Acquisitions (2021) Analysis & Trends
Kamada (KMDA) has reported Acquisitions for 1 consecutive years, with -$95.0 million the latest figure, recorded in Q4 2021.
- Quarterly Acquisitions changed N/A year-over-year to -$95.0 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was -$96.4 million (changed N/A YoY) and the FY2021 annual result came in at -$96.4 million, changed N/A from the prior year.
- Acquisitions slipped to -$95.0 million in Q4 2021 per KMDA's latest filing, from -$1.4 million in the prior quarter.
- Over the last five years, Acquisitions for KMDA reached as high as -$1.4 million in Q1 2021 and fell as low as -$95.0 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -95.00 Mn |
| Mar 31, 2021 | -1.40 Mn |